Abstract:Detecting and mapping metabolism in tissues represents a major step in detecting, characterizing, treating and understanding cancers. Recently introduced deuterium metabolic imaging techniques could offer a noninvasive route for the metabolic imaging of animals and humans, based on using 2H magnetic resonance spectroscopic imaging (MRSI) to detect the uptake of deuterated glucose and the fate of its metabolic products. In this study, 2H6,6′-glucose was administered to mice cohorts that had been orthotopically implanted with two different models of pancreatic ductal adenocarcinoma (PDAC), involving PAN-02 and KPC cell lines. As the tumors grew, 2H6,6′-glucose was administered as bolii into the animals' tail veins, and 2H MRSI images were recorded at 15.2 T. 2D phase-encoded chemical shift imaging experiments could detect a signal from this deuterated glucose immediately after the bolus injection for both the PDAC models, reaching a maximum in the animals' tumors ~ 20 min following administration, and nearly total decay after ~ 40 min. The main metabolic reporter of the cancers was the 2H3,3′-lactate signal, which MRSI could detect and localize on the tumors when these were 5 mm or more in diameter. Lactate production time traces varied slightly with the animal and tumor model, but in general lactate peaked at times of 60 min or longer following injection, reaching concentrations that were ~ 10-fold lower than those of the initial glucose injection. This 2H3,3′-lactate signal was only visible inside the tumors. 2H-water could also be detected as deuterated glucose's metabolic product, increasing throughout the entire time course of the experiment from its ≈10 mM natural abundance background. This water resonance could be imaged throughout the entire abdomen of the animals, including an enhanced presence in the tumor, but also in other organs like the kidney and bladder. These results suggest that deuterium MRSI may serve as a robust, minimally invasive tool for the monitoring of metabolic activity in pancreatic tumors, capable of undergoing clinical translation and supporting decisions concerning treatment strategies. Comparisons with in vivo metabolic MRI experiments that have been carried out in other animal models are presented and their differences/similarities are discussed.

Deuterium metabolic imaging of the human abdomen at clinical field strength

Development and optimization of human deuterium MRSI at 3 T in the abdomen: feasibility in renal tumors following oral heavy water administration

Deuterium metabolic imaging (DMI) for MRI-based 3D mapping of metabolism in vivo

Metabolic Imaging with Deuterium Labeled Substrates.

Deuterium MRSI characterizations of glucose metabolism in orthotopic pancreatic cancer mouse models

Deuterium MR spectroscopy: potential applications in oncology research

Review of a New Molecular Imaging Method——Deuterium Metabolic Spectroscopy and Imaging

Deuterium Metabolic Imaging Enables the Tracing of Substrate Fluxes Through the Tricarboxylic Acid Cycle in the Liver

Improving deuterium metabolic imaging (DMI) signal‐to‐noise ratio by spectroscopic multi‐echo bSSFP: A pancreatic cancer investigation

Deuterium Metabolic Imaging of Alzheimer Disease at 3-T Magnetic Field Strength: A Pilot Case-Control Study

Molecular imaging of tumor metabolism: Insight from pyruvate- and glucose-based deuterium MRI studies

Evaluation of Hepatic Glucose and Palmitic Acid Metabolism in Rodents on High‐Fat Diet Using Deuterium Metabolic Imaging

Application and Development of Deuterium Metabolic Imaging in Tumor Glucose Metabolism: Visualization of Different Metabolic Pathways

Glucose metabolism in brown adipose tissue determined by deuterium metabolic imaging in rats

In-vivo tracking of deuterium metabolism in mouse organs using LC-MS/MS

Proton/Deuterium Magnetic Resonance Imaging of Rodents at 9.4T Using Birdcage Coils

First in‐human evaluation of [1‐13C]pyruvate in D2O for hyperpolarized MRI of the brain: A safety and feasibility study

Noninvasive assessment of myocardial energy metabolism and dynamics using in vivo deuterium MRS imaging

Deuterium metabolic imaging differentiates glioblastoma metabolic subtypes and detects early response to chemoradiotherapy

Nimg-30. Deuterium Metabolic Imaging (Dmi) Shows A Strong Relation Between Tumor Grade And Glucose Metabolism In Primary Brain Tumors

Nimg-69. Interrogation Of Glioblastoma Fatty-Acid Synthesis And Metabolism With Deuterium Metabolic Imaging